Literature DB >> 23929344

The European BRCA patent oppositions and appeals: coloring inside the lines.

Gert Matthijs1, Isabelle Huys, Geertrui Van Overwalle, Dominique Stoppa-Lyonnet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23929344     DOI： 10.1038/nbt.2644

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  26 in total

1.  History of a gene patent: tracing the development and application of commercial BRCA testing.

Authors:  Bryn Williams-Jones
Journal:  Health Law J       Date:  2002

2.  Biomarker patents for diagnostics: problem or solution?

Authors:  Michael M Hopkins; Stuart Hogarth
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

3.  Legal uncertainty in the area of genetic diagnostic testing.

Authors:  Isabelle Huys; Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

Review 4.  Workshop on linkage studies of hereditary breast cancer.

Authors:  G M Lenoir; S A Narod; B A Ponder
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

5.  Genetic mapping of the BRCA1 region on chromosome 17q21.

Authors:  H Albertsen; R Plaetke; L Ballard; E Fujimoto; J Connolly; E Lawrence; P Rodriguez; M Robertson; P Bradley; B Milner
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

6.  Patently unpatentable: implications of the Myriad court decision on genetic diagnostics.

Authors:  Mildred Cho
Journal:  Trends Biotechnol       Date:  2010-11       Impact factor: 19.536

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

9.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  The next controversy in genetic testing: clinical data as trade secrets?

Authors:  Robert Cook-Deegan; John M Conley; James P Evans; Daniel Vorhaus
Journal:  Eur J Hum Genet       Date:  2012-11-14       Impact factor: 4.246
View more
  3 in total

1.  Are the gene-patent storm clouds dissipating? A global snapshot.

Authors:  Johnathon Liddicoat; Tess Whitton; Dianne Nicol
Journal:  Nat Biotechnol       Date:  2015-04       Impact factor: 54.908

2.  The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study.

Authors:  Bao-Chi Chang; Shyh-Jen Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Drug-resistance mechanisms and tuberculosis drugs.

Authors:  Claudio U Köser; Babak Javid; Kathleen Liddell; Matthew J Ellington; Silke Feuerriegel; Stefan Niemann; Nicholas M Brown; William J Burman; Ibrahim Abubakar; Nazir A Ismail; David Moore; Sharon J Peacock; M Estée Török
Journal:  Lancet       Date:  2015-01-24       Impact factor: 79.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.